day 1 agenda

                                                  Scientific Program
                   Day -1: July (19, 2023)
               Meeting Hall 1
08:00-09:00                        Registrations Open
09:00-09:15                        Opening Ceremony
                                                  Keynote Talks
09:15-09:45 Title: DNA Karyometry for Automated Detection of Cancer Cells
Alfred Bocking, Institute of Cytopathology,
 Dusseldorf , Germany
   
09:45-10:15                                     Title: TBA
Pran Datta, UAB Medicine - Hematology Oncology, United States
   
10:15-10:45 Title: Emerging Technologies in Interventional Oncology
Thomas Vogl, Frankfurt University Hospital, Germany
   
10:45-11:00 Group Photo & Refreshment Break
   
Morning Session:
Session Chairs:
Alfred Bocking, Institute of Cytopathology, Germany &
Thomas Vogl,
Frankfurt University Hospital, Germany 
 
11-00-11:20 Title: Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy
Yifan Li, Shanxi Cancer Hospital, China
 
11:20-11:40 Title: Targeting the Proteolysis of Mammalian SWI/SNF Chromatin Remodeling Complexes for Cancer Therapy
Hui Zhang, University of Nevada, United States
   
11:40-12:00 Title: Characterizing the dynamics of phosphoinositide variants in cancers
Takehiko Sasaki, Tokyo Medical and Dental University, Japan
   
12:00-12:20 Title: Targeting Wnt signalling at the level of the ligand/receptor in primary and metastatic cancer
Toby Phesse, Cardiff University, United Kingdom
 
12:20-12:40 Title: Using dual-loaded liposomal carriers to co-deliver a RanGTP inhibitory peptide and doxorubicin to overcome chemotherapeutic resistance in breast cancer cells.
Mohamed El-Tanani, Al-Ahliyya Amman, Jordan
 
12:40- 13:00 Title: Functional Analysis Provides Insight into Missing Heritability
Scott L. Baughan,  Wayne State University, United States
 
13:00-14:00 Lunch Break
   
Afternoon Session
                   Session Chairs: Yifan Li, Shanxi Cancer Hospital, China (&) Pran Datta, UAB Medicine - Hematology Oncology, United States
   
14:00-14:20 Title: Dynamic Gene Expression Analysis of Publically Available Gene Expression Data: Identifies Novel Genes Causing Endocrine Resistance in Breast Cancer 
Vahed Maroufy, University of texas Health Science at Houston, United States
 
14:20-14:40 Title: Targeting tumor-associated macrophages for cancer immunotherapy
Xiaopei Huang, The Ohio State University, United States
   
14:40-15:00 Title: Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy       
Yongju Gao, Henan Provincial People’s Hospital/Zhengzhou University, China
 
15:00-15:20 Title: PET/MR for the detection of Cancers of unknown primary site
Brunela Ronchi, FUESMEN, Argentina
   
15:20-15:40 Title: Nodule-type pneumonitis mimicking lung abscess or tumor recurrence on chest computed tomography identified as osimertinib-induced pneumonitis: A case report      
Ayumu Otsuki, Kameda Medical Center, Japan
   
15:40-16:00 Title: Improving Vibrational Spectroscopy Prospects in Frontline Clinical Diagnosis using FTIR     
Debdulal Roy, Swansea University, United Kingdom
   
16:00-16:10 Refreshment Break
   
16:10-16:30 Title: Variation in age-adjusted prostate cancer incidence rates by race and ethnicity after changes in prostate-specific antigen screening  
Sue M Lai, University of Kansas Medical Center, United States
   
16:30-16:50 Title: Molecular Characterization of Adenoid Cystic Carcinoma
Adel K. El-Naggar, The University of Texas, United States
   
16:50-17:10 Title: CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting
Kristopher Shawn LyBarger, Sarah Cannon Cancer Center-HCA MidAmerica, United States
   
17:10-17:30 Title: Crucial proteins involved in Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
Matilde Esther, Vall d´Hebron Research Institute, Spain
   
            Day-1 Concludes

day 2 agenda

                                                  Scientific Program
                     Day -2: July (20, 2023)
             Keynote Talks
09:00-9:30 Title: Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals
Keisuke Fukuchi, DAIICHI SANKYO CO., LTD., Japan
   
9:30-10:00 Title: Cytochrome c Acetylation in Prostate Cancer: Warburg Effect and Evasion of Apoptosis
Maik Huettemann, Wayne State University, United States
 
Morning Session
Session Chairs:
Mohamed El-Tanani,
Al-Ahliyya Amman, Jordan (&)
Debdulal Roy,
Swansea University, United Kingdom
 
10:00-10:20 Title: Quantum dots based in-vitro co-culture cancer model for identification of rare cancer cell heterogeneity
Anupalli Roja Ranii, Osmania University, India
   
10:20-10:40 Title: Comparison of the functional state and motor skills of patients after cerebral hemisphere, ventricular system, and cerebellopontine angle tumor surgery
Stanislaw Krajewski, University of Bydgoszcz, Poland
   
10:40-11:00 Title: Design and standard utilization of safety devices for the radiation treatment management of heavy patients
David Kanchaveli, Memorial Sloan Kettering Cancer Center, United States
   
11:00-11:20 Title: LOWER 24- MONTH RELATIVE SURVIVAL AMONG BLACK PATIENTS WITH NON- HODGKIN’S LYMPHOMA: AN ANALYSIS OF THE SEER DATA 1997-2015
Maria J Nieto, Northwell Health Cancer Institute, United States
   
11:20-11:40 Title: Could alkalization of the acidic tumor microenvironment contribute to the outcome of cancer treatment? Meaning and significance of “alkalization therapy for Cancer     
Reo Hamaguchi, Japanese Society on Inflammation and Metabolism in Cancer, Japan
   
11:40-12:00 Title: New gold (III) cyanide complex TGS121 induces ER stress, proteasome inhibition and death of Ras-hyperactivated cells    
Izabela Mlynarczuk-Bialy, Warsaw Medical University, Poland
   
12:00-12:20 Title: Drugging the undruggable: Small molecule inhibitors against the RNA Binding protein hnRNP A18 to simultaneously Inhibit Protein Translation and an Immune Checkpoint in Cancers
France Carrier, University of Maryland, Baltimore, United States
   
12:20-12:40 Title: A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology 
Mariusz Madej, Crown Bioscience, Netherlands
   
12:40-13:00 Title: Pediatric Spinal Hemangioblastomas: Clinical Features and Surgical Outcomes of 39 Case 
Wenqing Jia, Beijing Tiantan Hospital, Capital Medical University, China
   
13:00-14:00 Lunch Break
   
Afternoon Session
                   Session Chairs: Izabela Mlynarczuk-Bialy, Warsaw Medical University, Poland & Anupalli Roja Ranii, Osmania University, India
   
14:00-14:20 Title: Novel de Novo CDC42 Gene Defect causes Pancytopenia, Recurrent Infection, Poor Wound Healing, Heterotopia of the Brain: expanding the phenotype spectrum
Wafaa Mohammed AL Suwairi, KAMC-NGHA, Saudi Arabia
   
14:20-14:40 Title: Associations between nutrition risk scores and sarcopenia in gastrointestinal cancer patients: A cross-sectional study
Bo Gao, Nanjing University, China
   
14:40-15:00        SPEAKER SLOT AVAILABLE
   
15:00-15:20 Title: A randomized phase II study of 5-aminolevulinic acid hydrochloride and sodium ferrous citrate for the prevention of nephrotoxicity induced by cisplatin-based chemotherapy of lung cancer
Motowo Nakajima, SBI Pharmaceuticals, Japan
   
15:20-15:40 Title: Stromal Factors on Prostate Cancer Differentiation
Alvin Y Liu, University of Washington, United States
   
15:40-16:00 Title: Electrochemical immunosensors for detection and monitoring of breast and lung cancers
Iva Chianella, Cranfield University, United Kingdom
   
16:00-16:10 Refreshment Break
   
16:10-16:30 Title: Evolution of myeloma treatment patterns during and after COVID-19 pandemic period
Natalia Neparidze, Yale University/ yale Cancer Center, United States
   
16:30-16:50 Title: Correlation between serum cox 2 levels and development of hand foot syndrome     with capecitabine – an exploratory analysis from the d-torch study
Akhil Santhosh, All India Institute of Medical Sciences, India
   
16:50-17:10 Title: The function and mechanism of lncRNA ARHGAP5-AS1 on the Progression of Triple-negative breast cancer
Qian Zhao, Shanghai JiaoTong University School of Medicine, China
   
17:10-17:30        SPEAKER SLOT AVAILABLE
         Day-2 Concludes
Note: This is the tentative program only and the timings may be subject to change
Conference Hotel: Leonardo Royal Hotel Frankfurt
Mailander Str. 1, 60598 Frankfurt am Main, Germany
If any one interested to attend the conference or to book your speaker slot, please send an email to   cancercongress@innovincinternational.com

Virtual Agenda

                   Scientific Program
                     Day -1: July (19, 2023)
                     Virtual Presentations (Time zone: CET)
   
11:00-11:20 Title: Development of a breast cancercase management information platform(BC-CMIP)module based on patient-perceived value
Yinyin Liang,  The Second Affiliated Hospital of Chongqing Medical University, China
   
11:20-11:40 Title: MKL-1 Induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA mediated glycolysis
Yuan Wu, Huazhong University of Science and Technology, China
   
11:40-12:00        SPEAKER SLOT AVAILABLE
   
12:00-12:20 Title: A pan-cancer analysis of the oncogenic role of polypyrimidine tract binding protein 1 (PTBP1) in human tumors
Huang Qing, Xiamen Huaxia University, China
   
12:20-12:40 Title: Precise minimally invasive treatment of gastric cancer beyond the indications of endoscopic treatment with novel combined endoscopic and laparoscopic surgery
Guiyong Peng, Chongqing Southwest Hospita, China
   
12:40-13:00 Title: AI-assisted Laser-Induced Plasma Spectroscopy for Real-time, In Vivo Skin Cancer detection
Sung Hyun Pyun, Speclipse, Inc., Korea
   
13:00-13:20 Title: Intrinsic and chemically-induced daughter number variations in cancer
Hong XUE,  Hong Kong University of Science and Technology, China
   
13:20-13:40 Title: Assessment of breast cancer risk factors among pre and post-menopausal women
Ritu Yadav, Maharshi Dayanand University, India
   
13:40-14:00 Title: Has the COVID-19 pandemic affected the psychological state of Arab cancer patients?
Norah Abdullah Bazek Madkhali, Jazan university, Saudi Arabia
   
14:00-14:20 Title: Antibiotic prophylaxis in breast surgery a metaanalysis to identify the optimal strategy to reduce infection rates in breast surgery
Bader Alali,  Mubarak Al Kabeer Hospital, Kuwait
   
14:20-14:40 Title: Gluten Exorphins Promote Tumorigenesis in In Vitro Models of Human Lymphoma and Carcinoma
Federico Manai, University of Pavia, Italy
   
14:40-15:00 Title: Bromodomain-encoding epigenetic factors as potent regulators of cancer stemness
Patrycja Czerwinska, Poznan University of Medical Sciences, Poland
   
15:00-15:20 Title: Patients’ pathways to cancer care in Tanzania: documenting and addressing social inequalities in reaching a cancer diagnosis
Cristina Santos, The Open University, United Kingdom
   
15:20-15:40 Title: Effects of Bortezomib on the tumor immune microenvironment: Results from salivary gland carcinoma and mesothelioma mouse models
Camilla Palumbo, University of Rome "Tor Vergata", Italy
 
15:40-16:00 Title: Characterization of ovarian cancer symptoms in women without ovarian cancer
Lindsay Beechem, University of Kentucky College of Medicine, United States
   
16:00-16:20 Title: The humanized monoclonal ant CCR5 antibody blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy
Richard G Pestell, Baruch S Blumberg Institute, United States
   
16:20-16:40 Title: Comparing transcriptomic profiles from seven cell lines to elucidate liver metastatic potential
Lindsay R. Dresang, University of Wisconsin-Stevens Point, United States
   
16:40-17:00 Title: Anti-prostate cancer bone metastasis Radium223-based therapies a computational/experimental integrated approach
Stefano Casarin, Houston Methodist Research Institute, United States
   
17:00-17:20 Title: Evaluation of Alternatives to Logrank test in Immuno-Oncology Trials under Delayed Treatment Effect A Retrospective Analysis in Patients Treated with Anti-PD1/PD-L1 Agents across Solid Tumors
Pralay Mukhopadhyay, Otsuka America Pharmaceuticals Incorporated, United States
   
17:20-17:40 Title: Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients.
Olayinka Adebayo, Johnson & Johnson, United States
   
17:40-18:00 Title: Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network HospitalPeer Physician Coaching Between a Cancer Genetics Service and Community OncologistsPeer Physician Coaching Between a Cancer Genetics Service and Community Oncologists
Marianne Dubard-Gault, University of Washington, United States
                         Day-1 Concludes
Note: This is the tentative program only and the timings may be subject to change
Conference Hotel: Leonardo Royal Hotel Frankfurt
Mailander Str. 1, 60598 Frankfurt am Main, Germany
If any one interested to attend the conference or to book your speaker slot, please send an email to   cancercongress@innovincinternational.com

Virtual Agenda

                   Scientific Program
                     Day -2: July (20, 2023)
                     Virtual Presentations (Time zone: CET)
   
11:00-11:20 Title: Anti-transcriptional intermediary factor 1-γ antibody in cancer-assoicated myositis
Yoshinori Tanino, Fukushima Medical University, Japan
   
11:20-11:40        SPEAKER SLOT AVAILABLE
   
11:40-12:00 Title: Assessment of B7-H3 as a potent biomarker for predicting the radiosensitivity of IDH-wildtype Glioblastoma
Hui Wu, Affiliated Cancer Hospital of Zhengzhou University, China
   
12:00-12:20 Title: Application of Cytochrome C-Related Genes in Prognosis and Treatment Prediction of Lung Adenocarcinoma
Min Tang, Chongqing General Hospital, China
   
12:20-12:40 Title: TAPE-seq: A Cell-Based Method for Predicting Genome-Wide Off-Target Effects of Prime Editor
Jungjoon Lee, Toolgen, Korea
   
12:40-13:00 Title: Combination strategies to maximize the benefits of cancer immunotherapy
Shaoming Zhu, Beijing Chao-Yang Hospital, China
   
13:00-13:20 Title: INTEGRATION OF CONSOLIDATION CHEMOTHERAPY IN CERVICAL CANCER – THINKING BEYOND
Fatema Nedham, BDF hospital, Bahrain
   
13:20-13:40 Title: Mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells, and is indispensable for BT-20 cells in vitro
Alexander Weiss &Andreas Andric, University of Innsbruck, Austria
   
13:40-14:00 Title: Revolutionizing Cancer Care - Personalized Treatment powered by comprehensive Tumor Profiling in NEBC
Dörthe Schaffrin-Nabe, Praxis für Hämatologie und Onkologie, Germany
   
14:00-14:20 Title: Impact of Doxorubicin on Cell-Substrate Topology
Herbert Schneckenburger,  Schneckenburger, Germany
   
14:20-14:40 Title: The antiproliferative effect of cannabidiol in cancer cells is modulated by its physical state and by growth factors
Alessia D'Aloia, University of Milano-Bicocca, Italy
   
14:40-15:00 Title: Investigating the role of non-canoncial Wnt planar cell polarity during normal prostate tissue homeostasis and prostate cancer
Helen Pearson, Cardiff University, United Kingdom
   
15:00-15:20 Title: SMAD4 governs a feedforward regulation of the TGF-β-effects in CD8 T cells that contributes to preventing chronic intestinal inflammation, a fertile soil for cancer
Saidi Soudja, Centre de Recherche en cancérologie de Lyon, France
   
15:20-15:40 Title: Measurement of Irritability in Cancer Patients
Amy Zhang, Case Western Reserve University, United States
   
15:40-16:00 Title: Role of timing of steroid use on clinical outcomes of immune checkpoint inhibitor – A population based study
Nikita Nikita, Thomas Jefferson University, United States
   
16:00-16:20 Title: The interplay between apurinic/apyrimidinic endonuclease 1 (APE1) and DNA G-quadruplex (G4) in regulating triple-negative breast cancer (TNBC) metastasis.
Kishor K. Bhakat, University of Nebraska Medical Center, United States
   
16:20-16:40 Title: Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer
Elnaz Naderi, Columbia University Medical center, United states
   
16:40-17:00 Title: Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma
Scott A. Weed, West Virginia University Cancer Institute, United States
   
17:00-17:20 Title: Tissue transglutaminase: a new target at the interface with the ovarian cancer stem cell niche
Salvatore Condello, Indiana University School of Medicine, United States
   
17:20-17:40 Title: ChoK-full of potential: Choline kinase in B cell and T cell malignancies
Ping Xie, Rutgers University, United States
   
17:40-18:00 Title: Interfering with Lipid Metabolism through Targeting CES1 Sensitizes Hepatocellular Carcinoma for Chemotherapy
Kai Sun, University of Texas Health Science Center, United States
   
18:00-18:20 Title:Genomic alterations associated with onset and development of angioimmunoblastic T-cell lymphoma and concomitant hematologic neoplasms
Shuhua Cheng, Icahn School of Medicine at Mount Sinai, United States
   
18:20-18:40 Title: New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune-checkpoint inhibitors
Ahmad Sufian Bin Ab Rahman, Linear Clinical Research, Perth, Australia
   
18:40-19:00        SPEAKER SLOT AVAILABLE
                         Day-2 Concludes
Note: This is the tentative program only and the timings may be subject to change
Conference Hotel: Leonardo Royal Hotel Frankfurt
Mailander Str. 1, 60598 Frankfurt am Main, Germany
If any one interested to attend the conference or to book your speaker slot, please send an email to   cancercongress@innovincinternational.com

Download